Could a cancer drug slow Alzheimer's? new trial aims to find out.
NCT ID NCT05564169
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 25 times
Summary
This phase 3 trial tests whether masitinib, a drug that targets immune cells in the brain, can help people with mild Alzheimer's when added to their current treatment. About 600 participants will receive either masitinib or a placebo for 24 weeks. The study measures changes in thinking skills and daily activities to see if the drug slows decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ace Alzheimer Center Barcelona (Fundació ACE)
Barcelona, Spain
-
Complejo Asistencial de Zamora. Hospital Provincial de Zamora
Zamora, Spain
-
Hospital Clinico Universitario Virgen de la Arrixaca
Murcia, Spain
-
Hospital Policlínico de Gipuzkoa
Donostia / San Sebastian, Spain
-
Hospital Universitario Nuestra Señora del Perpetuo Socorro de Albacete (Hospital Universitario Nuestra Señora del Perpétuo Socorro)
Albacete, Spain
-
Hospital Universitario de Navarra
Pamplona, Spain
-
Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universitaires Pitié-Salpêtrière
Paris, France
-
La Paz University Hospital (Hospital Universitario La Paz)
Madrid, Spain
-
Virgen de las Nieves University Hospital (Hospital Universitario Virgen de las Nieves)
Granada, Spain
Conditions
Explore the condition pages connected to this study.